🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a a Multicenter, Open-label, Single-arm, Phase Ib Dose Escalation a...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-02-03
Trial ID
NCT04178460
Treatments Being Tested
This is an open-label, multi-cohort, multi-center Phase I clinical trial to...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-10-29
Trial ID
NCT04653038
Treatments Being Tested
This is an open-label study designed to evaluate safety and efficacy of eno...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-10
Trial ID
NCT04129320
Treatments Being Tested
This is a Phase 2 study of enoblituzumab combined with either retifanlimab ...
Status
Terminated
Location
University of Maryland, Greenebaum Comprehensive Cancer Center
Start Date
2021-03-17
Trial ID
NCT04634825
Treatments Being Tested
This study consists of two parts: Phase I is a dose escalation study to det...
Status
Terminated
Location
Prince of Wales Hospital
Start Date
2020-04-20
Trial ID
NCT04212221
Treatments Being Tested
This is a Phase 2/3, randomized, open-label study for the treatment of pati...
Status
Completed
Location
Mayo Clinic - Scottsdale
Start Date
2019-09-30
Trial ID
NCT04082364
Treatments Being Tested
The primary goal of this Phase 1 study is to characterize the safety and to...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2017-08-18
Trial ID
NCT03219268